LPL Financial’s Marker Therapeutics MRKR Stock Holding History

LPL Financial’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122K	Buy	83,147 +100	+0.1%	+$146	﹤0.01%	5885
2026 Q1	$108K	Sell	83,047 -200	-0.2%	-$317	﹤0.01%	5661
2025 Q4	$124K	Buy	83,247 +24,500	+42%	+$27.7K	﹤0.01%	5559
2025 Q3	$52.4K	Sell	58,747 -15,000	-20%	-$18.5K	﹤0.01%	5627
2025 Q2	$113K	Buy	73,747 +520	+0.7%	+$668	﹤0.01%	5244
2025 Q1	$90.1K	Sell	73,227 -6,503	-8%	-$11.9K	﹤0.01%	5067
2024 Q4	$248K	Buy	+79,730	New	+$282K	﹤0.01%	4674
2020 Q4	–	Sell	-1,565	Closed	-$23K	–	3841
2020 Q3	$23K	Hold	1,565	–	–	﹤0.01%	3496
2020 Q2	$32K	Hold	1,565	–	–	﹤0.01%	3385
2020 Q1	$30K	Buy	+1,565	New	+$39.9K	﹤0.01%	3118

Other funds holding MRKR

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

LPL Financial's MRKR Position: Q2 2026 in Review

LPL Financial increased its Marker Therapeutics (MRKR) stake by 0.12% in Q2 2026, buying an estimated $146 and bringing the position to 83,147 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #5885.

LPL Financial first reported a position in MRKR in Q1 2020 and has held it in 10 quarters since. The position peaked at $248K in Q4 2024. 25 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

LPL Financial held 83,147 shares of Marker Therapeutics worth $122K as of Q2 2026.
LPL Financial bought 100 Marker Therapeutics shares in Q2 2026, an estimated $146.
Marker Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5885 holding.
LPL Financial first reported a position in Marker Therapeutics in Q1 2020 and has held it in 10 quarters since.
LPL Financial's Marker Therapeutics position peaked at $248K in Q4 2024.
25 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.